Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Abstract Text:

Gloria Lena Vega,Myron F Weiner,

A number of epidemiologic studies suggest an association between plasma total cholesterol and risk for Alzheimer's disease (AD). Additionally, it has been suggested that treatment with statins, drugs that block cholesterol biosynthesis, lower the incidence and prevalence of AD and of vascular dementia. This review provides an overview of cholesterol transport within the central nervous system and the impact of statins on brain cholesterol metabolism in subjects with AD. Brain cholesterol is converted to 24-S-hydroxycholesterol, a reaction catalyzed by CYP46. The oxysterol traverses the blood-brain barrier and is transported to the liver by plasma lipoproteins. The levels of 24-S-hydroxy-cholesterol are a reflection of brain cholesterol turnover. Subjects with AD reportedly have high levels of the oxysterol possibly reflecting neuronal death with release of cell membrane cholesterol. We show gender dimorphism in plasma levels of 24-S-hydroxycholesterol in subjects with AD and significant reductions in plasma levels of the oxysterol during treatment with standard doses of statins (lovastatin, simvastatin, and pravastatin). Polymorphisms of apolipoprotein E and CYP46 do not influence the effect of statins on plasma levels of 24-S-hydroxycholesterol. There were no untoward effects of the standard doses of statin for the duration of treatment. Statins are currently in trial to determine their effect on the course of AD.

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Publishing Authors By Initials

GL Vega,MF Weiner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of molecular neuroscience : MN

VOLUME: 33

Page Numbers: 51-5

Journal Abbreviation: J. Mol. Neurosci.

ISSN: 0895-8696

DAY: 28

MONTH: Sep

YEAR: 2007

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9002991

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.

AFFILIATION: The Nutrition and Metabolism Laboratory, Metabolic Unit, Veterans Affairs Medical Center, Dallas, TX 75390, USA. Gloria.Vega@utsouthwestern.edu

Country: United States

AGENCY: United States NIA

GRANT: P30-AG12300

ACRONYM: AG

MEDLINETA: J Mol Neurosci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms Related Publications

• A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios.
• ADCS Prevention Instrument Project: quality of life assessment (QOL).
• Adapting a dynamic model of interorganizational cooperation to the health care sector.
• Anisotropic Poisson's ratio and compression modulus of cortical bone determined by speckle interferometry.
• Bayesian parallel imaging with edge-preserving priors.
• Binding of mitochondrial leader sequences to Tom20 assessed using a bacterial two-hybrid system shows that hydrophobic interactions are essential and that some mutated leaders that do not bind Tom20 can still be imported.
• Biomechanical properties of the lower uterine segment above and below the reflection of the urinary bladder flap.
• Cardiovascular disease and subsequent kidney disease.
• Caregiving burden responses differ for Internet and telephone data collection.
• Chronic low back pain in older adults: What physicians know, what they think they know, and what they should be taught.
• Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
• Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner.
• Delivery of drugs and macromolecules to mitochondria.
• Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
• Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
• Electronic health records: high-quality electronic data for higher-quality clinical research.
• Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney.
• How the parallel channels of the retina contribute to depth processing.
• Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T.
• Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
• Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
• Recovery preference exploration: analysis of patient feedback after imagined scenarios.
• Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerases.
• Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.
• Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
• Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
• The hairless mouse ear: an in vivo model for studying wound neovascularization.
• The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b.
• Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis.
• X-ray absorption spectroscopic characterization of the molybdenum site of Escherichia coli dimethyl sulfoxide reductase.